This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

BUENOS AIRES (Reuters) -They look like ordinary foals, docile with honey brown coats and white facial patches, content to spend their days munching alfalfa in a cordoned-off pasture in rural Buenos ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without ...

CRISPR Technology Turns 10, Rises to New Challenges Ever since CRISPR technology arrived, it has been refining its capabilities and tackling increasingly difficult problems—including problems of ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

The world's first gene-edited horses in Argentina are making waves in polo, showcasing advances in CRISPR technology.

You've probably heard about the gene-editing technology CRISPR. The massive biotech breakthrough, which has emerged in the last decade, has mainly been touted for the ways it will let scientists edit ...

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...